ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,172Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1137

$1.7M Total Retail Price of All Prescriptions

Rank: 10 out of 1137

666 Patients Receiving at Least One Drug in Part D
62% Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oklahoma
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 666 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 666 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 714 422 130 1 2
OMEPRAZOLE 700 381 114 2 4
FUROSEMIDE 670 534 118 3 5
AMLODIPINE BESYLATE 601 499 105 4 7
MELOXICAM 542 309 113 5 17
HYDROCODONE-ACETAMINOPHEN 527 342 124 S3 6 1
PRAVASTATIN SODIUM 486 345 103 7 15
POTASSIUM CHLORIDE 449 376 101 8 10
CITALOPRAM HBR 442 278 68 9 18
METOPROLOL TARTRATE 436 309 70 10 13
METFORMIN HCL 419 254 63 11 8
TRAMADOL HCL 385 257 101 12 14
LEVOTHYROXINE SODIUM 348 251 55 13 3
GABAPENTIN 337 222 61 14 11
CARVEDILOL 314 268 49 15 22
RISPERIDONE 299 119 50 A 16 71
FENOFIBRATE* 270 152 63 17 94
FLUTICASONE PROPIONATE 256 126 88 18 27
NEXIUM 235 120 36 19 32
ATORVASTATIN CALCIUM 232 201 44 20 9
TRIAMTERENE-HCTZ 227 162 50 21 91
ZOLPIDEM TARTRATE 224 111 39 22 20
SIMVASTATIN 213 96 42 23 6
SPIRIVA 207 132 38 24 55
METOPROLOL SUCCINATE 205 118 34 25 23
CLONAZEPAM 204 116 34 B 26 50
TAMSULOSIN HCL 199 94 30 27 30
SERTRALINE HCL 197 88 35 28 28
DICLOFENAC SODIUM 190 105 38 29 117
PANTOPRAZOLE SODIUM 187 120 37 30 38
KLOR-CON M20 187 118 34 30 99
AMITRIPTYLINE HCL 184 116 29 R 32 75
SUCRALFATE 182 136 43 33 129
CLOPIDOGREL 175 110 32 34 19
TRAZODONE HCL 174 14 29 35 35
PIOGLITAZONE HCL 172 115 22 R 36 90
PROAIR HFA 169 76 69 37 33
ISOSORBIDE MONONITRATE ER 167 119 30 38 81
LORAZEPAM 162 88 37 B 39 40
QUETIAPINE FUMARATE 154 46 25 A 40 65
FLUOXETINE HCL 154 44 24 40 41
CLONIDINE HCL 153 76 26 42 45
ATENOLOL 152 114 27 43 26
MONTELUKAST SODIUM 152 85 20 43 52
POLYETHYLENE GLYCOL 3350 149 98 40 45 46
CRESTOR 148 96 33 46 39
ADVAIR DISKUS 147 86 41 47 51
BENZTROPINE MESYLATE 147 27 20 R 47 180
GEMFIBROZIL 143 93 22 49 107
ABILIFY 140 51 17 A 50 98
AZITHROMYCIN 134 81 101 51 44
HYDROXYZINE HCL 123 32 21 R 52 146
ALPRAZOLAM 122 62 22 B 53 16
PREDNISONE 121 80 66 54 49
PROMETHAZINE HCL 120 60 33 R 55 86
TIZANIDINE HCL 118 27 27 56 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 118 61 24 56 24
WARFARIN SODIUM 118 90 21 56 21
HYDROCHLOROTHIAZIDE 117 81 24 59 12
DIOVAN 116 102 15 60 56
NAMENDA 115 86 19 61 25
CYCLOBENZAPRINE HCL 113 17 27 R 62 43
OLANZAPINE 113 53 17 A 62 111
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 67 72 64 79
LEVOFLOXACIN 104 63 70 65 87
DONEPEZIL HCL 99 94* 18 66 31
CIPROFLOXACIN HCL 98 79 70 67 62
INVEGA SUSTENNA 95 0 13 A 68 305
SPIRONOLACTONE 94 65 17 69 83
GLIPIZIDE 94 68 12 69 57
NYSTATIN 93 51 32 71 126
FENTANYL 92 66 18 S2 72 76
MECLIZINE HCL 91 55 25 73 173
GLYBURIDE 90 32 11 R 74 80
AMLODIPINE BESYLATE-BENAZEPRIL 89 84* 16 75 88
FENOFIBRATE* 88 <11 <11 76 94
TOPIRAMATE 87 13 18 77 153
ROPINIROLE HCL 83 57 17 78 70
LOVASTATIN 82 <11 <11 79 47
MIRTAZAPINE 79 53 19 80 54
DICYCLOMINE HCL 78 46 21 81 205
ENALAPRIL MALEATE 77 29 16 82 64
RANITIDINE HCL 77 43 13 82 34
VALPROIC ACID* 76 <11 <11 84 290
CARBIDOPA-LEVODOPA 75 <11 <11 85 125
TEMAZEPAM 75 49 22 B 85 66
ALLOPURINOL 72 67* 16 87 37
NOVOLOG 72 52 12 87 108
LEVETIRACETAM 71 <11 <11 89 113
LEVEMIR 71 42 13 89 116
DOXAZOSIN MESYLATE 71 45 13 89 92
METOCLOPRAMIDE HCL 70 38 16 92 139
VENLAFAXINE HCL ER 69 <11 <11 93 95
PAROXETINE HCL 68 28 12 94 59
CARBAMAZEPINE 67 <11 <11 95 213
DOXYCYCLINE HYCLATE 65 35 39 96 177
HYDRALAZINE HCL 64 <11 <11 97 138
LANTUS 63 <11 <11 98 61
OXYBUTYNIN CHLORIDE 63 58* 12 98 118
TORSEMIDE 62 57* 12 100 128
OXYBUTYNIN CHLORIDE ER 61 <11 <11 101 119
JANUVIA 60 34 11 102 73
NIASPAN 59 27 11 103 199
METHOCARBAMOL 58 23 13 R 104 167
LITHIUM CARBONATE 57 <11 <11 105 251
SYMBICORT 57 28 11 105 160
CLOZAPINE 56 <11 <11 A 107 155
PHENYTOIN SODIUM EXTENDED 56 <11 <11 107 140
XOPENEX HFA 56 <11 <11 107 336
OXYCODONE HCL-ACETAMINOPHEN 54 <11 19 S2 110 72
ZETIA 54 32 21 110 100
ESCITALOPRAM OXALATE 54 <11 <11 110 48
DIVALPROEX SODIUM 53 <11 <11 113 89
PRADAXA 53 <11 <11 113 215
AVODART 53 <11 <11 113 220
LOSARTAN POTASSIUM 53 <11 <11 113 29
LYRICA 52 22 14 117 53
AMOX TR-POTASSIUM CLAVULANATE 52 37 39 117 137
ZIPRASIDONE HCL 51 <11 <11 A 119 250
ETODOLAC 50 <11 <11 120 152
HALOPERIDOL 50 <11 12 A 120 194
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.